news.frx.com

'); Global Sites Countries Country Sites Countries Country Sites Argentina Argentina Site Australia Australia Site Austria Austria Site Bahrain Bangladesh Barbados Belgium Belgium Site Bolivia Brazil Brazil Site Canada Canada Site Chile Chile Site China (Mainland) China (Mainland) Site Colombia Colombia Site Costa Rica Czech Republic Czech Republic Site Denmark Dominican Republic Ecuador Egypt El Salvador Finland France France Site Germany Germany Site Greece Guatemala Honduras Hong Kong (China) Hungary India India Site Indonesia Ireland Ireland Site Israel Italy Italy Site Jamaica Japan Japan Site Jordan Korea Korea Site Kuwait Lebanon Malaysia Mexico Mexico Site Netherlands Netherlands Site New Zealand New Zealand Site Norway Pakistan Palestine Panama Peru Philippines Poland Poland Site Portugal Portugal Site Puerto Rico Romania Russia Russia Site Saudi Arabia Serbia Serbia Site Singapore Slovakia South Africa South Africa Site Spain Spain Site Sri Lanka Sweden Sweden Site Switzerland Switzerland Site Taiwan (China) Taiwan (China) Site Thailand Trinidad & Tobago Turkey Turkey Site Ukraine United Arab Emirates United Kingdom United Kingdom Site United States United States Site Uruguay Venezuela Vietnam Yemen Global / USA Investors Careers Contact Products Key Therapeutic Areas Central Nervous System Key Products BOTOX® (onabotulinumtoxinA) Product Details BOTOX® (onabotulinumtoxinA) For Providers Prescribing Information, including Boxed Warning Medication Guide Safety Data Sheet For Patients Patient Assistance Program botox.com NAMZARIC® (memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use Product Details NAMZARIC® (memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use For Providers Prescribing Information Safety Data Sheet For Patients Patient Assistance Program namzaric.com VRAYLAR® (cariprazine) capsules, for oral use Product Details VRAYLAR® (cariprazine) capsules, for oral use For Providers Prescribing Information, including Boxed Warnings Safety Data Sheet For Patients Patient Assistance Program vraylar.com All Central Nervous System Products Eye Care Key Products LUMIGAN® 0.01% (bimatoprost ophthalmic solution) Product Details LUMIGAN® 0.01% (bimatoprost ophthalmic solution) For Providers Prescribing Information For Patients Patient Assistance Program lumigan.com OZURDEX® (dexamethasone intravitreal implant) 0.7 mg Product Details OZURDEX® (dexamethasone intravitreal implant) 0.7 mg For Providers Prescribing Information Safety Data Sheet ozurdex.com REFRESH® Portfolio of Consumer Eye Care Products Product Details REFRESH® Portfolio of Consumer Eye Care Products refreshbrand.com All Eye Care Products Gastroenterology Key Products LINZESS® (linaclotide) capsules, for oral use Product Details LINZESS® (linaclotide) capsules, for oral use For Providers Prescribing Information, including Boxed Warning Safety Data Sheet For Patients Patient Assistance Program linzess.com VIBERZI® (eluxadoline) tablets, for oral use, CIV Product Details VIBERZI® (eluxadoline) tablets, for oral use, CIV For Providers Prescribing Information Safety Data Sheet For Patients Patient Assistance Program viberzi.com ZENPEP® (pancrelipase) delayed release capsules Product Details ZENPEP® (pancrelipase) delayed release capsules For Providers Prescribing Information Safety Data Sheet For Patients Patient Assistance Program zenpep.com All Gastroenterology Products Medical Aesthetics Key Products BOTOX® Cosmetic (onabotulinumtoxinA) Product Details BOTOX® Cosmetic (onabotulinumtoxinA) For Providers Prescribing Information, including Boxed Warning Medication Guide Safety Data Sheet botoxcosmetic.com COOLSCULPTING® Product Details COOLSCULPTING® coolsculpting.com JUVÉDERM® Ultra Product Details JUVÉDERM® Ultra For Providers Directions for Use For Patients Patient Labeling juvederm.com SkinMedica® Product Details SkinMedica® skinmedica.com All Medical Aesthetics Products Patient Assistance Programs View All Products About About Allergan About Allergan Executive Leadership Business Development Supplier Relations Patent Notices Media Resources Allergan For Patients & Caregivers Healthcare Providers Investors Careers R&D R&D Pipeline Clinical Trials Innovation Pre-Approval Access Responsibility Responsibility at Allergan Community Environmental & Sustainability Social Contract Patient Safety & Product Quality Healthcare Provider Partnerships & Payments Alliance Advocacy Support Public Policy California Supply Chain Disclosure Menu Close Global / USA Home Products Key Therapeutic Areas Central Nervous System Eye Care Gastroenterology Medical Aesthetics Patient Assistance Programs View All Products About About Allergan About Allergan Executive Leadership Business Development Supplier Relations Patent Notices Media Resources R&D R&D Pipeline Clinical Trials Innovation Pre-Approval Access Responsibility Responsibility at Allergan Community Environmental & Sustainability Social Contract Patient Safety & Product Quality Healthcare Provider Partnerships & Payments Alliance Advocacy Support Public Policy California Supply Chain Disclosure Investors Media Patients Providers Careers Contact Central Nervous System Key Products View All Central Nervous System Products BOTOX® (onabotulinumtoxinA) NAMZARIC® (memantine hydrochloride extended-release and donepezil hydrochloride) capsules, for oral use VRAYLAR® (cariprazine) capsules, for oral use Eye Care Key Products View All Eye Care Products LUMIGAN® 0.01% (bimatoprost ophthalmic solution) OZURDEX® (dexamethasone intravitreal implant) 0.7 mg REFRESH® Portfolio of Consumer Eye Care Products Gastroenterology Key Products View All Gastroenterology Products LINZESS® (linaclotide) capsules, for oral use VIBERZI® (eluxadoline) tablets, for oral use, CIV ZENPEP® (pancrelipase) delayed release capsules Medical Aesthetics Key Products View All Medical Aesthetics Products BOTOX® Cosmetic (onabotulinumtoxinA) COOLSCULPTING® JUVÉDERM® Ultra SkinMedica® Investors Investors Events & Presentations Corporate & Financial Information Corporate Information: Executives & Leadership Corporate Governance Committee Composition Committee Charters Acquisition of Allergan by AbbVie Financials: Annual Reports Quarterly Results SEC Filings Insider Transactions Proxy Materials Shareholder Resources Shareholder Services & Investor Kit Information Request Form Email Alerts Dividends Investor FAQ Stock information Stock Information Stock Information Historic Stock Look-Up Analyst Coverage Investment Calculator Media Media Company Profile Executive Bios & Photos images Videos Patients Patients Providers Providers Medical Information Request Careers Careers Search Careers All Years All Years 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 All Article Blog Press Release About Allergan All Products Contact Compliance Privacy Terms California Privacy Sitemap Copyright © 2020 Allergan X This website uses cookies and other technologies to personalize content and to show you more personalized ads (for example, Google Ads and Facebook) on this and other websites, as well as provide you with social media features on this website (such as, Facebook, Twitter, LinkedIn). By clicking “Accept” you understand that you are directing Allergan to disclose your personal information, including internet tracking data (like cookies and the IP address you used to access this website), to these third parties for the purposes stated above. You can still use this website if you do not click “Accept,” but your experience may be different. For more information, including information on the categories of third parties to whom we disclose your personal information, please refer to our global privacy policies, available at www.allergan.com/privacy . For additional options please check your browser...